Biden's prostate cancer described as 'aggressive' — what to know about the disease's prognosis

Prostate cancer cases have been on the rise in current years increasing annually since and now former President Joe Biden is one of the more than men to be diagnosed this year Biden's office issued the announcement on Sunday days after news that a small nodule had been ascertained in the former president's prostate during a routine exam While this represents a more aggressive form of the infection the cancer appears to be hormone-sensitive which allows for effective management his office reported The president and his family are reviewing rehabilitation options with his physicians NEW PROSTATE CANCER TEST PINPOINTS SYNDROME BETTER THAN PSA OPTION ASSESSMENT FINDSTreatment is usually more effective when prostate cancer is hormone-sensitive as that means the malady will likely respond better to hormone therapy according to Mayo Clinic Hormone therapy is used to block the effects of the hormones that fuel the upsurge of prostate cancer cells Prostate cancer cells rely on testosterone to help them grow Cutting off the supply of testosterone may cause cancer cells to die or to grow more slowly the above source stated In addition to hormone therapy common healing options for prostate cancer include chemotherapy targeted therapy immunotherapy and radiopharmaceutical treatments Prostate cancer is a affection unveiled in men that develops in the prostate gland About new cases of prostate cancer will be diagnosed in and men will die from the syndrome according to the American Cancer Society One in eight men will be diagnosed with prostate cancer in their lifetime the same source stated Older men are at a higher threat of the sickness with six in cases diagnosed in patients and older The average age at evaluation is with men under rarely affected Biden is PROSTATE CANCER DRUG NOW AVAILABLE TO MORE PATIENTS WITH AGGRESSIVE FORM OF DISEASEProstate cancer is the second-most common cancer in men behind only skin cancer the ACS noted Among men who undergo routine prostate cancer screening the illness is usually caught early before reactions emerge per the ACS Typical early reactions include problems urinating a weak or slow urinary stream or an increased need to urinate Various men may also notice blood in the urine or bodily fluids More advanced signs may occur after the ailment has spread Those may include pain in the hips back spine chest ribs or other areas the ACS stated Men may also suffer from erectile dysfunction weight loss extreme fatigue weakness in the legs or feet or loss of bladder or bowel control The U S Preventive Services Task Force states that men aged to years should have the option to undergo periodic prostate-specific antigen PSA -based screening to monitor for prostate cancer Before deciding whether to be screened men should have an opportunity to discuss the foreseen benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision the USPSTF states While screening offers a small anticipated benefit of reducing the chances of dying from the affection the agency noted that specific men may experience negative effects including false-positive results overdiagnosis and overtreatment and recovery complications Alternative prostate cancer screening methods are at the moment being researched including one that uses a non-invasive urine test as Fox News Digital in the past few days released For localized prostate cancers where the syndrome is contained within the prostate the five-year survival rate is at least according to the ACS CLICK HERE TO SIGN UP FOR OUR WELLBEING NEWSLETTERFor regional cases where the affection has spread only to nearby structures or lymph nodes the five-year survival rate is also or greater For more Soundness articles visit www foxnews com healthIf the cancer has spread to other areas of the body the five-year survival rate drops to Actual survival rates may vary based on the patient's age overall medical how the cancer has progressed post-diagnosis the disease's response to restoration and other factors the ACS noted